Recently, it has been reported that a high density of intra-tumoral CD8+ T cells was associated with better outcomes, while a high regulatory T cell (Tregs)-to-Teffs ratio was associated with a reduced clinical benefit in HCC patients treated with Ate/Bev [6]. Here, CD8A is linked to hepatocellular carcinoma.